KARVEZIDE Safety Questions, KARVEZIDE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about KARVEZIDE. Our extensive database of KARVEZIDE adverse events and KARVEZIDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about KARVEZIDE
KARVEZIDE Safety Reports
Total KARVEZIDE reports: 11.KARVEZIDE FDA safety alerts: No.
Reported hospitalizations: 4.
Take KARVEZIDE Side Effects Survey or Share Your KARVEZIDE Story. Read More Here.
Physician from AUSTRALIA reported KARVEZIDE problem on Feb 23, 2007. Female patient, 70 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, proctalgia. KARVEZIDE dosage: unknown. During the same period patient was treated with TRITACE. Patient recovered.
KARVEZIDE problem was reported by a Health Professional from AUSTRALIA on Mar 01, 2007. Female patient, 68 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. KARVEZIDE dosage: unknown. During the same period patient was treated with IRBESARTAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported KARVEZIDE problem on Aug 17, 2006. Female patient was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: renal impairment. KARVEZIDE dosage: 300MG/ 12.5 MG TAKEN IN THE MORNING. During the same period patient was treated with KARVEA, LIPITOR, ASPIRIN, DIAMICRON, AVANDIA. Patient was hospitalized. Patient recovered.
KARVEZIDE problem was reported by a Consumer or non-health professional from SPAIN on Sept 20, 2006. Female patient was diagnosed with hypertension and was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: liver disorder, muscle spasticity, paraesthesia, paralysis, polyuria, sensory loss. KARVEZIDE dosage: PRODUCT STRENGTH = 300/12.5 MG. During the same period patient was treated with CODEINE PHOSPHATE, OMEPRAZOLE, NEURONTIN, METFORMIN, GLIPIZIDE, DIAZEPAM, NEOBRUFEN, TRANSTEC. Patient recovered.
Physician from GERMANY reported KARVEZIDE problem on Oct 06, 2006. Female patient, 77 years of age, weighting 187.4 lb, was diagnosed with hypertension, intervertebral disc disorder and was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis. KARVEZIDE dosage: unknown. During the same period patient was treated with MOBIC. Patient recovered.
KARVEZIDE problem was reported by a Health Professional from AUSTRALIA on Oct 16, 2006. Female patient, 85 years of age, weighting 110.2 lb, was diagnosed with hypertension, gout, depression, sleep disorder and was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, hyponatraemia. KARVEZIDE dosage: unknown. During the same period patient was treated with BETALOC, NORVASC, PROGOUT, ZOLOFT, TEMAZE, TIMOPTIC. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported KARVEZIDE problem on Oct 23, 2006. Female patient, 90 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypokalaemia, hyponatraemia. KARVEZIDE dosage: unknown. Patient was hospitalized. Patient recovered.
KARVEZIDE problem was reported by a Pharmacist from GERMANY on Oct 23, 2006. Female patient, 68 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. KARVEZIDE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, CORIFEO, ALLOPURINOL, SIMVASTATIN. Patient recovered.
Pharmacist from GERMANY reported KARVEZIDE problem on Oct 23, 2006. Female patient, 68 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. KARVEZIDE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, CORIFEO, ALLOPURINOL, SIMVASTATIN. Patient recovered.
KARVEZIDE problem was reported by a Consumer or non-health professional from SPAIN on Sept 20, 2006. Female patient was diagnosed with hypertension and was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, muscle spasticity, paraesthesia, paralysis, polyuria, sensory loss. KARVEZIDE dosage: PRODUCT STRENGTH = 300/12.5 MG. During the same period patient was treated with CODEINE PHOSPHATE, OMEPRAZOLE, NEURONTIN, METFORMIN, GLIPIZIDE, DIAZEPAM, NEOBRUFEN, TRANSTEC. Patient recovered.
Pharmacist from GERMANY reported KARVEZIDE problem on Oct 23, 2006. Female patient, 68 years of age, was treated with KARVEZIDE. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. KARVEZIDE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, CORIFEO, ALLOPURINOL, SIMVASTATIN. Patient recovered.